Ignite Creation Date:
2024-05-05 @ 4:52 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00338312
Status:
COMPLETED
Last Update Posted:
2013-04-17
First Post:
2006-06-15
Brief Title:
Study of Transdermal Testosterone Patches in Naturally Menopausal Women With Low Libido
Sponsor:
Warner Chilcott
Organization:
Warner Chilcott
Study Overview
Official Title:
A Study to Evaluate the EfficacySafety of Transdermal Testosterone for 52 Weeks and Safety for 52 Weeks in Naturally Menopausal Women With Hypoactive Sexual Desire Disorder on Oral Hormone Replacement Therapy
Status:
COMPLETED
Status Verified Date:
2013-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is designed to evaluate efficacy and safety of a testosterone patch as treatment for low libido in naturally menopausal women who are taking estrogen or estrogenprogestin therapy
Detailed Description:
Naturally menopausal women with hypoactive sexual desire disorder HSDD were randomized into a 52-week multicenter double-blind DB parallel-group placebo-controlled study Patients were stratified based on presenceabsence of uterus and randomized to receive placebo or testosterone transdermal system Patients had to maintain a stable dose of estrogenprogestin throughout the study Patients who completed the first 52 weeks of the study were given the opportunity to participate in year 2-4 open-label active treatment study extension which was added to the protocol by amendment Safety was assessed by adverse events lipids serum chemistry with hepatic renal and carbohydrate metabois in evaluation coagulation testing and hermatology Physical exam including clinical assessments of facial hair and acne were monitored
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None